[Podcast] Cellular Agriculture and the Evolving Legal/Regulatory Landscape: A Conversation with Ahmed Khan
The U.S. Food and Drug Administration (FDA) continues to advance the Trump administration’s Make America Healthy Again (MAHA) priorities by increasing scrutiny of chemicals in the food supply and accelerating the shift away...more
This regular publication by DLA Piper lawyers focuses on helping clients navigate the ever-changing business, legal, and regulatory landscape. FDA releases 2026 deliverables for Human Foods Program. On January 23, the Food...more
The U.S. Food and Drug Administration (FDA) Human Foods Program (HFP) published its 2026 Priority Deliverables, outlining a broad agenda under the Trump administration’s Make America Healthy Again (MAHA) strategy to advance...more
The Make America Healthy Again (MAHA) Commission released the Make Our Children Healthy Again Strategy (MAHA Strategy) this week. Consistent with the MAHA Strategy’s overall theme of increasing transparency and trust with the...more
Key Takeaways - What Happened: The Make America Healthy Again (MAHA) Commission has released its final Make Our Children Healthy Again Strategy report. The Strategy outlines extensive executive branch actions intended to...more
Key Takeaways - What Happened: A leaked draft of the Make Our Children Healthy Again Strategy (the Make America Healthy Again (MAHA) Commission’s action plan) is circulating. The draft outlines extensive executive branch...more
The U.S. Food and Drug Administration (FDA) is overhauling its approach to post-market oversight of food chemicals, marked by the proposed rollout of a new Post-Market Assessment Prioritization Tool. The FDA first announced...more